{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00778",
      "entity_text" : "antithrombin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_E031" ],
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0547" ],
      "Organ" : [ "uberon:UBERON:0014899" ]
    }
  },
  "verbose_text" : "Methods We retrospectively analyzed all consecutive children (< = 18 years) with ALL, treated on the Dutch Childhood Oncology Group (DCOG) ALL-9 and ALL-10 protocols at the Emma Children 's Hospital Academic Medical Center between February 1997 and January 2012, to study the effect of FFP on VTE incidence, antithrombin and fibrinogen plasma levels, and VTE risk factors.",
  "reading_complete" : "2020-08-03T13:10:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:08:57Z",
  "trigger" : "levels",
  "evidence" : [ "antithrombin and fibrinogen plasma levels" ],
  "pmc_id" : "6524923",
  "score" : 0
}